short-limbed dwarfism

BioMarin's dwarfism therapy gets FDA nod for expanded use
Reuters
Mon, 10/23/23 - 09:08 am
BioMarin Pharmaceutical
short-limbed dwarfism
FDA
Voxzogo
Pfizer agrees on $340M upfront to buy Therachon for dwarfism drug
Fierce Biotech
Wed, 05/8/19 - 10:42 am
Pfizer
Therachon
short-limbed dwarfism
M&A